KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Evolent Health (EVH) Return on Invested Capital (2016 - 2025)

Historic Return on Invested Capital for Evolent Health (EVH) over the last 11 years, with Q3 2025 value amounting to 0.02%.

  • Evolent Health's Return on Invested Capital rose 100.0% to 0.02% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.02%, marking a year-over-year increase of 100.0%. This contributed to the annual value of 0.04% for FY2024, which is 100.0% up from last year.
  • According to the latest figures from Q3 2025, Evolent Health's Return on Invested Capital is 0.02%, which was up 100.0% from 0.03% recorded in Q2 2025.
  • In the past 5 years, Evolent Health's Return on Invested Capital registered a high of 0.0% during Q4 2022, and its lowest value of 0.39% during Q1 2021.
  • For the 5-year period, Evolent Health's Return on Invested Capital averaged around 0.05%, with its median value being 0.03% (2025).
  • Within the past 5 years, the most significant YoY rise in Evolent Health's Return on Invested Capital was 4500bps (2021), while the steepest drop was -1600bps (2021).
  • Quarter analysis of 5 years shows Evolent Health's Return on Invested Capital stood at 0.06% in 2021, then skyrocketed by 102bps to 0.0% in 2022, then plummeted by -2975bps to 0.04% in 2023, then grew by 2bps to 0.04% in 2024, then soared by 40bps to 0.02% in 2025.
  • Its Return on Invested Capital was 0.02% in Q3 2025, compared to 0.03% in Q2 2025 and 0.03% in Q1 2025.